Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Published Online
on March 3, 2008

Circulation. 2008
Published online before print March 3, 2008, doi: 10.1161/CIRCULATIONAHA.107.727420
A more recent version of this article appeared on March 18, 2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
117/11/1388    most recent
CIRCULATIONAHA.107.727420v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Landa, N.
Right arrow Articles by Leor, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Landa, N.
Right arrow Articles by Leor, J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*ALGINIC ACID
Medline Plus Health Information
*Heart Attack
Related Collections
Right arrow Other myocardial biology
Right arrow Other heart failure
Right arrow Myogenesis
Right arrow CV surgery: transplantation, ventricular assistance, cardiomyopathy
Right arrow Acute myocardial infarction
Right arrowRelated Article

Submitted on July 13, 2007
Accepted on January 18, 2008

Effect of Injectable Alginate Implant on Cardiac Remodeling and Function After Recent and Old Infarcts in Rat

Natali Landa BSc, Liron Miller MSc, Micha S. Feinberg MD, Radka Holbova BSc, Michal Shachar PhD, Inbar Freeman MSc, Smadar Cohen PhD*, and Jonathan Leor MD*

From the Neufeld Cardiac Research Institute, Sheba Medical Center, Tel-Aviv University, Tel-Hashomer (N.L., L.M., M.S.F., R.H., J.L.) and Department of Biotechnology Engineering, Ben-Gurion University of the Negev, Beer-Sheva (M.S., I.F., S.C.), Israel.

* To whom correspondence should be addressed. E-mail: scohen{at}bgu.ac.il or leorj{at}post.tau.ac.il.

Background—Adverse cardiac remodeling and progression of heart failure after myocardial infarction are associated with excessive and continuous damage to the extracellular matrix. We hypothesized that injection of in situ–forming alginate hydrogel into recent and old infarcts would provide a temporary scaffold and attenuate adverse cardiac remodeling and dysfunction.

Methods and Results—We developed a novel absorbable biomaterial composed of calcium-crosslinked alginate solution, which displays low viscosity and, after injection into the infarct, undergoes phase transition into hydrogel. To determine the outcome of the biomaterial after injection, calcium-crosslinked biotin-labeled alginate was injected into the infarct 7 days after anterior myocardial infarction in rat. Serial histology studies showed in situ formation of alginate hydrogel implant, which occupied up to 50% of the scar area. The biomaterial was replaced by connective tissue within 6 weeks. Serial echocardiography studies before and 60 days after injection showed that injection of alginate biomaterial into recent (7 days) infarct increased scar thickness and attenuated left ventricular systolic and diastolic dilatation and dysfunction. These beneficial effects were comparable and sometimes superior to those achieved by neonatal cardiomyocyte transplantation. Moreover, injection of alginate biomaterial into old myocardial infarction (60 days) increased scar thickness and improved systolic and diastolic dysfunction.

Conclusions—We show for the first time that injection of in situ–forming, bioabsorbable alginate hydrogel is an effective acellular strategy that prevents adverse cardiac remodeling and dysfunction in recent and old myocardial infarctions in rat.


Key words: collagen • heart failure • myocardial infarction • remodeling • tissue • tissue engineering


Related Article:

Clinical Summaries
Circulation 2008 117: 1353. [Extract] [Full Text]



This article has been cited by other articles:


Home page
J Am Coll CardiolHome page
J. Leor, S. Tuvia, V. Guetta, F. Manczur, D. Castel, U. Willenz, O. Petnehazy, N. Landa, M. S. Feinberg, E. Konen, et al.
Intracoronary injection of in situ forming alginate hydrogel reverses left ventricular remodeling after myocardial infarction in Swine.
J. Am. Coll. Cardiol., September 8, 2009; 54(11): 1014 - 1023.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
T. Dvir, A. Kedem, E. Ruvinov, O. Levy, I. Freeman, N. Landa, R. Holbova, M. S. Feinberg, S. Dror, Y. Etzion, et al.
Prevascularization of cardiac patch on the omentum improves its therapeutic outcome
PNAS, September 1, 2009; 106(35): 14990 - 14995.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
T. Wang, D.-Q. Wu, X.-J. Jiang, X.-Z. Zhang, X.-Y. Li, J.-F. Zhang, Z.-B. Zheng, R. Zhuo, H. Jiang, and C. Huang
Novel thermosensitive hydrogel injection inhibits post-infarct ventricle remodelling
Eur J Heart Fail, January 1, 2009; 11(1): 14 - 19.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. A. Kloner and H. Hwang
New Insights Into the Open Artery Hypothesis
Circ. Res., July 3, 2008; 103(1): 1 - 3.
[Full Text] [PDF]